AIMT - Aimmune Therapeutics Inc. (AIMT) CEO Jayson Dallas on Q1 2020 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q1 2020 Earnings Conference Call
May 11, 2020 16:30 ET
Company Participants
DeDe Sheel - Vice President, Investor Relations
Jayson Dallas - President & Chief Executive Officer
Andrew Oxtoby - Chief Commercial Officer
Eric Bjerkholt - Chief Financial Officer
Daniel Adelman - Chief Medical Officer
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Kennen MacKay - RBC Capital Markets
Brian Skorney - Baird
Zegbeh Jallah - Roth Capital Partners
Liisa Bayko - JMP Securities
Paul Choi - Goldman Sachs
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome